{
      "brief_title": [
            "etanercept",
            "psoriasis",
            "pediatrics"
      ],
      "brief_summary": [
            "study",
            "evaluate",
            "safety",
            "efficacy",
            "etanercept",
            "child",
            "psoriasis",
            "phase",
            "3",
            "blind",
            "study"
      ],
      "condition": [
            "psoriasis"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "placebo"
      ],
      "description": [
            "intend",
            "dose",
            "50",
            "mg",
            "weekly"
      ],
      "arm_group_label": [
            "placebo"
      ],
      "criteria": [
            "patient",
            "plaque",
            "psoriasis",
            "patient",
            "may",
            "receive",
            "certain",
            "psoriasis",
            "medication",
            "study"
      ],
      "gender": [],
      "minimum_age": [
            "4",
            "year"
      ],
      "maximum_age": [
            "17",
            "year"
      ],
      "healthy_volunteers": false,
      "id": "NCT00078819.xml"
}